These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1388841)

  • 21. Differential recruitment of viral and allo-epitopes into the MHC class I antigen processing pathway of a novel mutant of Ltk- cells. HSV/MHC class I restriction/immune recognition/antigen processing/antigen presentation/influenza virus.
    Lippé R; Kolaitis G; Michaelis C; Tufaro F; Jefferies WA
    J Immunol; 1993 Apr; 150(8 Pt 1):3170-9. PubMed ID: 7682234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunology. Accessory to murder.
    Schumacher TN
    Nature; 1999 Mar; 398(6722):26-7. PubMed ID: 10078525
    [No Abstract]   [Full Text] [Related]  

  • 23. Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway.
    Rötzschke O; Falk K
    Immunol Today; 1991 Dec; 12(12):447-55. PubMed ID: 1723878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen processing mutant T2 cells present viral antigen restricted through H-2Kb.
    Zhou X; Glas R; Liu T; Ljunggren HG; Jondal M
    Eur J Immunol; 1993 Aug; 23(8):1802-8. PubMed ID: 8393799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diverse repertoire of the MHC class II-peptide complexes is required for presentation of viral superantigens.
    Golovkina T; Agafonova Y; Kazansky D; Chervonsky A
    J Immunol; 2001 Feb; 166(4):2244-50. PubMed ID: 11160278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFN-gamma-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides.
    Jefferies WA; Kolaitis G; Gabathuler R
    J Immunol; 1993 Sep; 151(6):2974-85. PubMed ID: 8397249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reassociation with beta 2-microglobulin is necessary for Db class I major histocompatibility complex binding of an exogenous influenza peptide.
    Rock KL; Gamble S; Rothstein L; Benacerraf B
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):301-4. PubMed ID: 1986378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Clonal analyses of human CD8+ class I MHC-restricted CTL.
    van Binnendijk RS; Poelen MC; Kuijpers KC; Osterhaus AD; Uytdehaag FG
    J Immunol; 1990 Mar; 144(6):2394-9. PubMed ID: 2107259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reassociation with beta 2-microglobulin is necessary for Kb class I major histocompatibility complex binding of exogenous peptides.
    Rock KL; Rothstein LE; Gamble SR; Benacerraf B
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7517-21. PubMed ID: 2217182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species specificity in the interaction of CD8 with the alpha 3 domain of MHC class I molecules.
    Newberg MH; Ridge JP; Vining DR; Salter RD; Engelhard VH
    J Immunol; 1992 Jul; 149(1):136-42. PubMed ID: 1607650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of genetic variations on MHC class I antigen-processing genes in human cancer and viral-mediated diseases.
    D'Alicandro V; Romania P; Melaiu O; Fruci D
    Mol Immunol; 2019 Sep; 113():11-15. PubMed ID: 29625843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells.
    Jaraquemada D; Marti M; Long EO
    J Exp Med; 1990 Sep; 172(3):947-54. PubMed ID: 2388037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coupling and cross-presentation.
    Heath WR; Carbone FR
    Nature; 2005 Mar; 434(7029):27-8. PubMed ID: 15744280
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER.
    Aladin F; Lautscham G; Humphries E; Coulson J; Blake N
    Cancer Immunol Immunother; 2007 Aug; 56(8):1143-52. PubMed ID: 17143611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: a study with transgenic mice.
    Kievits F; Wijffels J; Lokhorst W; Ivanyi P
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):617-20. PubMed ID: 2783490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters.
    Lobigs M; Müllbacher A
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2676-80. PubMed ID: 8464875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4.
    Levitsky V; Zhang QJ; Levitskaya J; Masucci MG
    J Exp Med; 1996 Mar; 183(3):915-26. PubMed ID: 8642295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitating presentation of MHC class I-restricted antigens.
    Chen W; Bennink JR; Yewdell JW
    Methods Mol Biol; 2001; 156():245-54. PubMed ID: 11068765
    [No Abstract]   [Full Text] [Related]  

  • 40. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG; Biddison WE; Klausner RD
    Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.